Efficacy of tiludronate in the treatment of horses with signs of pain associated with osteoarthritic lesions of the thoracolumbar vertebral column.

The research examines the use of tiludronate in treating horses suffering from pain associated with osteoarthritic conditions affecting the thoracolumbar vertebral column. The findings suggest it can significantly improve back flexibility and reduce pain in affected horses, therefore, it could be a potential treatment for managing pain associated with intervertebral lesions.

Research Methodology

• The researchers selected a total of 29 horses exhibiting clinical signs of pain linked to lesions of the thoracolumbar vertebral column and showing radiographic evidence of osteoarthritis of the articular processes-synovial intervertebral joints.
• A standard protocol, including radiographic, ultrasonographic and scintigraphic examinations, was followed for the initial examination of the horses.
• Out of the total, 15 horses were randomly chosen to receive tiludronate (delivered intravenously at 1 mg/kg, at a slow-rate infusion) while the remainder were given a control substance.
• The horses were observed for the ensuing 120 days with clinical evaluations conducted on the 60th and 120th days.
• Horses showing no signs of clinical improvement on the 60th day were then given tiludronate.
• Statistical analyses were carried out to compare the effectiveness of the treatment at the end of 60 days, the improvement in dorsal flexibility at the end of 120 days, and the difference in dorsal flexibility before and after 60 days of tiludronate administration.

Research Findings

• There was a noteworthy improvement in dorsal flexibility between days 0 and 60 in horses that received tiludronate. This was in comparison to those horses that received the control substance.
• This improvement in dorsal flexibility was still noticeable at the mark of 120 days.
• The number of positive responses in the group that received tiludronate was higher at 60 days as compared to the control group.
• These results revealed that tiludronate was effective in treating pain in horses arising from osteoarticular lesions of the thoracolumbar vertebral column.

Conclusions

• Based on the research, tiludronate was proven to bring about significant improvements to dorsal flexibility.
• The study suggests that tiludronate could provide a potential treatment option for the management of intervertebral lesions and the associated pain in horses.